Characterizing the metabolic divide: distinctive metabolites differentiating CAD-T2DM from CAD patients.

"Declarations Ethics approval and consent to participateThe study adhered to the guidelines of the Helsinki Declaration and received ethics approval from the Medical Ethical Review Committee of Guangdong Provincial People’s Hospital (GDREC2010137 and GDREC2017071H). All participants provided written informed consent. Consent for publicationNot applicable. Competing interestsAuthors have nothings to be disclosed. The authors declare that they have no competing interests. Competing interests Authors have nothings to be disclosed. The authors declare that they have no competing interests."

"Funding This study was supported by the National Natural Science Foundation of China (No. 82274016, 82003746, 81872934), the Science and Technology Program of Guangzhou (No. 2023B03J1251, 2023A04J0542), Guangdong Basic and Applied Basic Research Foundation (No. 2023A1515011133), the Key-Area Research and Development Program of Guangdong Province, China (No. 2019B020229003), and National key research and development program (No. 2017YFC0909301)."